AI assistant
Sending…
Passage BIO, Inc. — Director's Dealing 2022
Mar 23, 2022
34849_dirs_2022-03-23_1cb1982f-7ac4-46c6-bfae-4bded775bece.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Passage BIO, Inc. (PASG)
CIK: 0001787297
Period of Report: 2022-03-21
Reporting Person: Goldsmith Bruce A (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-21 | Common Stock | P | 10000 | $3.15 | Acquired | 15983 | Direct |
More from Passage BIO, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Director's Dealing
2026
Mar 18
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3